Intelligent bio solutions to highlight proprietary drug testing technology at 2025 ndasa conference and trade show

New york, march 28, 2025 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) ("inbs" or the "company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its participation as a gold sponsor at the 2025 national drug and alcohol screening association (ndasa) conference and trade show, taking place from april 1 – 4 in jacksonville, florida. daniel brown, head of clinical affairs at intelligent bio solutions, will present at the international symposium on tuesday, april 1, at 1:00 pm.
inbs Ratings Summary
inbs Quant Ranking